Hem › Njurcancer › Massachusetts › Boston
Kliniska studier för Njurcancer i Boston, MA
12 studier för Njurcancer söker deltagare vid platser i och runt Boston (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Distance-Based Exercise to Preserve Function and Prevent Disability
Rekryterar
- Dana-Farber Cancer Institute, Boston
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
RekryterarFas 3
- Research Site, Boston
- Research Site, Boston
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
RekryterarFas 1/2
- Brigham and Women's Hospital, Boston
- Dana Farber/Mass General Brigham Cancer Care, Inc, Boston
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
RekryterarFas 1
- Research Site, Boston
A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma
RekryterarFas 2
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
RekryterarFas 1
- Dana-Farber Cancer Institute, Boston
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
RekryterarFas 1
- Dana-Farber Cancer Institute, Boston
Video Education With Result Dependent dIsclosure
Rekryterar
- Dana Farber Cancer Institute, Boston
Drug Screening Using Novel IMD in Renal Cell Carcinoma
RekryterarFas 1
- Dana-Farber Cancer Institute, Boston
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
RekryterarFas 1/2
- Massachusetts General Hospital, Boston
Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC
RekryterarFas 2
- Beth Israel Deaconess Medical Center, Boston
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Stereotactic Magnetic Resonance Guided Radiation Therapy
Rekryterar
- Brigham & Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
Njurcancer-studier i andra städer
- New York City, NY15 studier
- Nashville, TN12 studier
- Houston, TX10 studier
- Washington, DC9 studier
- San Diego, CA9 studier
- St. Louis, MO9 studier
- Dallas, TX9 studier
- Seattle, WA8 studier
- Edison, NJ8 studier
- Jacksonville, FL7 studier
- Los Angeles, CA7 studier
- Baltimore, MD7 studier
Andra studier i Boston
- Bröstcancer111 studier
- Icke-småcellig lungcancer90 studier
- Cancer (alla typer)86 studier
- Kolorektal cancer63 studier
- Metastaserande cancer63 studier
- Lungcancer62 studier
- Äggstockscancer61 studier
- Prostatacancer59 studier
- Depression52 studier
- Endometriecancer50 studier
- Hjärtsvikt44 studier
- Akut myeloid leukemi44 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.